These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 789414)

  • 41. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent diabetes insipidus associated with pregnancy: pathophysiology and therapy.
    Hughes JM; Barron WM; Vance ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):462-4. PubMed ID: 2915875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with DDAVP in central diabetes insipidus. Review of our experience].
    Bernasconi S; Vanelli M; Volta C; Solli R; Cavagni G; Giovannelli G
    Minerva Pediatr; 1978 Jul; 30(13):1111-4. PubMed ID: 672852
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas.
    Sheehan JM; Sheehan JP; Douds GL; Page RB
    Acta Neurochir (Wien); 2006 Mar; 148(3):287-91; discussion 291. PubMed ID: 16362179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin) in the treatment of diabetes insipidus in children.
    Némethová V; Lichardus B
    Endokrinologie; 1974 Mar; 63(1):137-41. PubMed ID: 4611759
    [No Abstract]   [Full Text] [Related]  

  • 49. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 50. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
    Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
    Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of diabetes insipidus].
    Boscaro M; Mani E; Pistorello M; Rampazzo A
    Minerva Endocrinol; 1990; 15(1):95-9. PubMed ID: 2274021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
    J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP; Borbély L
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus].
    Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F
    Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diabetes insipidus. Diagnosis and treatment with DDAVP (Minurin)].
    Steiness I
    Ugeskr Laeger; 1976 Jun; 138(25):1505-10. PubMed ID: 936314
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
    Rampazzo AL; Boscaro M; Mantero F; Piccitto R
    Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
    Tuschy U; Meinhold J; Szeszat S
    Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes insipidus: clinical and basic aspects.
    Majzoub JA; Srivatsa A
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():60-5. PubMed ID: 17261971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.